Tech Company Financing Transactions
Limelight Bio Funding Round
On 12/9/2019, Limelight Bio raised $75 million in funding from Apple Tree Partners.
Transaction Overview
Company Name
Announced On
12/9/2019
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3401 Grays Ferry Ave.
Philadelphia, PA 19146
USA
Philadelphia, PA 19146
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Limelight Bio is pioneering new therapies that break down barriers of current genetic medicine to bring hope to as many patients and families as possible. Since 2017, Limelight has been developing proprietary technologies, advanced targets, and leading drug candidates designed to overcome key limitations of current gene therapy and gene editing approaches.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Ehlers
Chief Operating Officer
David Shin
Chief Scientific Officer
Philip Johnson
VP - Bus. Development
Jessica Imrie
Browse more venture capital transactions:
Prev: 12/9/2019: Vroom venture capital transaction
Next: 12/9/2019: AutoPets venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs